Overview
The customer is a global Biopharmaceutical company and one of the largest harmaceutical companies by both market capitalization and sales with $40 Billion annual turnovers and global footprints in 140 countries. The company is committed to deliver innovative health solutions.
Challenges
- Non-Availability of tools to examine the complete array of checks for validating the contents of Define.xml
- Automation Process was not feasible as XML Map software was being used to get all the metadata into SAS datasets in required format
- It was a daunting task to accommodate all these measures
- Frequent use of services from an external specialist for any Ad-hoc request that emerged when the metadata evolved during the trial
Outcomes
Eliminated extra steps used in XML Map and other external software in Define.xml validation process and the manual steps that followed for formatting the metadata dataset
Process automation was made possible for an end-to-end solution
Augmented the ability to extract different parts of Define.xml metadata for selective validation needs
Built an in-house Define.xml validation process which offers more than what other external software can provide, getting rid of the need to depend on the services of a specialist in Define.xml